|
Flat growth curve. Two months without an increase in weight age of an infant below the 90th percentile weight age. ; Laboratory tests Hct 33% Hgb 11 gm dL 6-12 months ; 15 g dL blood lead level Health problems Metabolic disorder. Chronic disease requiring a special diet. Physical handicap or developmental delay which may alter nutritional status.
Pediatric therapy
Choletithiasis cholecystitis ; . 4. Contact pediatric hematologist or patient's primary physician with expertise in sickle cell disease. 5. Treatment discuss with patient, family, and hematologist or primary physician on-call ; a. Mild to moderate pain: Acetaminophen with codeine 1 mg kg po and then q 4 hr ; and oral fluids If inadequate relief within 30 min, follow b, below Consider starting ibuprofen 10 mg kg po q 6-8 h or other anti-inflammatory agent if no contraindication present i.e. gastritis, ulcer, coagulopathy, or renal impairment ; . Limit more frequent dosing to 72 hr maximum duration. If adequate relief and no other acute complications present, discharge on oral analgesics acetaminophen with codeine and or ibuprofen ; . b. Moderate to severe pain: Morphine 0.1-0.15mg kg IV. Reassess pain q 15-30 min. Patients with severe pain may require repeated doses of morphine 0.02-0.05 mg kg IV q 15-30 min to achieve pain relief. Alternative analgesics, such as hydromorphone Dilaudid ; 0.015-0.02 mg kg IV, may be appropriate in individual cases. Ketorolac Toradol ; 0.5 mg kg 30 mg maximum dose ; IV may be used in addition to opioid analgesia if no contraindication i.e., gastritis, ulcer, coagulopathy, dehydration or renal impairment ; . Do not use ibuprofen with ketorolac. Repeated doses of meperidine Demerol ; should be avoided because of the risk of seizures. IV fluids: 10 cc kg bolus over 1 hr then maintenance rate. Excessive fluids should be avoided unless patient is judged dehydrated. Monitor pulse ox. Use O2 by nasal cannula or face mask if needed to keep O2 saturation 92% or patient's baseline value, if 92%. The etiology of a supplemental O2 requirement should be investigated. If adequate pain relief with one or two doses of morphine, consider giving acetaminophen with codeine 1 mg kg ; as outpatient therapy. Consider hospitalization for around-the-clock parenteral analgesics if more than one or two doses of morphine required.
Allen and Rosenberg: PHAEOCHROMOCYTOMA AS ACUTE MH dependent manner 84 per cent inhibition at 10 |xM concentration ; .17 Presumably, dantrolene affects calcium messenger systems in the adrenal medulla.18 Sumikawa et al.l6 have suggested that part of the therapeutic action of dantrolene may be to attenuate the sympathetic response that occurs during an acute MH episode. In conclusion, the development of a hypermetabolic state during anaesthesia is not pathognomonic of MH. Other causes must be considered, particularly when unusual responses to treatment occur. References 1 Rosenberg H. Clinical presentation of malignant hypcrthermia. Br J Anaesth 1988; 60: 268-73. Fletcher JE, Rosenberg H. Laboratory methods for malignant hypcrthermia diagnosis. In: Williams CH Ed. ; , Experimental Malignant Hyperthermia. New York: Springer-Vcrlag, 1988; 121-40. 3 Kirkendall WM, Liechty RD, Culp DA. Diagnosis and treatment of patients with phaeochromocytoma. Arch IntMed 1965; 115: 529-36. Kirby BD, Ham J, Fairley HB, Benowitz N, Schambelan M. Normotensive phaeochromocytoma: pharmacologic, paraneoplastic, and anaesthetic considerations. West J Med 1983; 139: 221-5. Simon HB, Daniels GH. Hormonal hyprathermia: endocrinologic causes of fever. J Med 1979; 66: 257-63. Madias NE, Goorno WE, Herson S. Severe lactic acidosis as a presenting feature of phaeochromocytoma. J Kid Dis 1987; 10: 250-3. Bornemann M, Hill SC, Kidd GS. Lactic acidosis in phcochromocytoma. Ann Int Med 1986; 105: 880-2. Keller U, Mall T, Walter M, Bertel O, Mihatsch JM, Rite R. Phaeochromocytoma with lactic acidosis. Br Med J 1978; 2: 606-7. Steward DA. Malignant hyperthermia - the acute crisis. Int Anesthesiol Clin 1979; 17: 1-9. Larach MG, Rosenberg H, Larach DR, Broennly AM. Prediction of malignant hyperthermia susceptibility by clinical signs. Ancsthcsiology 1987; 66: 547-50. GronertGA. Malignant hyperthermia. In: Miller RD Ed. ; . Anesthesia, 2nd ed. New York: Churchill-Livingstone, 1986: 1971-94. 12 Kaufman BH, Telander RL, van Heerden JA, Zimmerman D, Sheps SG, Dawson B. Pheochromocytoma in the pediatric age group: current status. J. Ped Surgery 1983; 18: 879-84.
Women's health pediatric products net revenues of the women's health pediatric products namely, the prenate line, the tanafed line, robinul and ponstel ; were approximately 2 million for the quarter ended march 31, 200 total prescriptions of the tanafed line decreased 4% for the quarter ended march 31, 2004 compared to the quarter ended march 31, 2003 source: ims health's national prescription audit plus tm ; data ; which was in line with the weakening of the flu season.
PATIENT POPULATION One hundred thirty-three pediatric kidney transplantations have been performed at the Children's Hospital and Regional Medical Center, University of Washington, Seattle, from March 1, 1984, through December 31, 1999. Eighty-eight children 66% ; were recipients of adult living donor LD ; kidneys; 45 34% ; received cadaveric donor kidneys. Twenty-eight 32% ; of the 88 LD recipients were infants or small children weighing less than 20 kg. Overall, 33 patients weighed less than 20 kg, of whom 28 85% ; received LD kidney transplants. The medical records of these 28 LD kidney recipients were retrospectively reviewed. Patient demographic data including age, weight, sex, and origin of renal disease were recorded. Pretransplantation dialysis requirement and mode of dialysis were noted. Transplantation data including site of vascular anastomoses, size of donor kidney if available ; , cold ischemia time, and early graft function were noted. Immunosuppression was according to our protocol and is described below. SURGICAL MANAGEMENT Donor nephrectomy and recipient transplantation operations were performed simultaneously in adjoining operating rooms by independent surgical teams. The donor nephrectomy was done through a flank approach and a brisk diuresis 100-200 mL h ; was induced using aggressive intravascular volume expansion with crystalloid and albumin colloid solutions. A combination of mannitol and furosemide was occasionally used, and some donors were systemically heparinized prior to cross-clamping the renal vessels. Recipient hemodynamic monitoring included central venous pressure CVP ; through an internal jugular vein or subclavian vein catheter. Initial CVP measurements ranged from 0 to 5 Hg, and aggressive intravenous crystalloid and colloid fluids were given to achieve a CVP of 16 to the time of vascular unclamping. A few of the patients had radial arterial catheters to help with blood pressure management. Some patients required transfusion of packed red blood cells for dilutional anemia or plasma for coagulopathy. Many patients required ventilatory assistance postoperatively for 1 to 2 days!
Chemet is the only fda-approved drug indicated for the treatment of lead poisoning in pediatric patients with blood lead levels in excess of 45 ug and pegasys.
Buy generic Pediatric online
Figure 1. You Are Logged ON 2. When you are finished, and exit the Internet, the BRCS log-on page disappears and you are returned to your Desktop. BUT THE CONNECTION IS STILL ACTIVE . until you right-click on the computer symbol and left-click on Disconnect on the popup.
Pediatric ointment
2 2005 Lower genital tract disease in children and adolescents - A review Heller, D.S. Journal of Pediatric and Adolescent Gynecology 18 2 ; , pp. 75-83 and pegfilgrastim.
A total of 3, 251 organisms were analyzed as follows: Aerococcus spp. 22 ; , Bacillus spp. 202; two species groups ; , Corynebacterium spp. 342; five species ; , enterococci 378; six species ; , Listeria monocytogenes 137 ; , Micrococcus luteus 29 ; , Rothia mucilaginosus 18 ; , -haemolytic streptococci not group A or B 865; three serogroups ; and viridans group streptococci 1, 258; 12 species see Tables 1 and 2. All identifications were initially made at the participant sites and confirmed at the central laboratory by conventional reference methods and commercial systems Vitek and Vitek 2, bioMerieux, Hazelwood, MO.
Considering the changing economic and social environment and the need for upliftment of the SC ST families, which form nearly 18% of the population of Delhi, it was considered necessary that some Coaching- cum- Guidance facilities may be created for SC ST candidates registered with the Employment Exchanges which may enable them to increase their representation in Public Services and promote their employability. It was thus decided to conduct regular training in typing and stenography including General Knowledge and English for these candidates and provide them guidance for career planning and confidence building by arranging special lectures and pegvisomant.
These agents, as well as formulations containing divalent or trivalent cations or other buffering ingredients, such as videx ò , didanosine ; , chewable buffered or the pediatric oral solution, should be taken at least two hours before or two hours after oral trovafloxacin administration see clinical pharmacology.
Oviduct to adrenergic drugs has suggested that the sympathetic nervous system is involved in tubal function, controlling oviductal contractility and hence ovum transport Brundin, 1965; Pauerstein et al., 1973; Polidoro et al., 1973 ; . Specifically it has been proposed that the oviductal isthmus functions as an adrenergic sphincter which is under hormonal Quantitative oviduct regulation studies have sup1974; the influduring Reports oviductal et et al., Pauerstein et al., 1974a ; . of adrenoceptors of rabbit ported this concept Higgs Hodgson and Pauerstein, question ence on as to oviductal the degree contractile and pemetrexed.
For treatment, implies a strong need for more active involvement of pediatric psychologists and other mental health professionals in the pediatric primary care arena. In such a setting, psychologists could be playing a role in problem identification, assessment, intervention, and prevention. Rational planning for the kinds of problems that might present in primary care settings depends on an understanding of the types of problems, time of onset, and factors associated with their occurrence. Within a pediatric setting, where children have more frequent contacts with physicians before the age of 5 years than later, understanding the problems of young children is particularly important. Psychologists working in pediatric specialty care often deal with significant but relatively rare problems. Primary care may need to emphasize the more common psychological disorders of childhood. The two major categories of childhood psychological problems are disruptive e.g., attention deficit, oppositional defiant disorder ; and emotional anxiety disorders, depression ; disorders. The intraindividual stability e.g., how likely a child with a particular disorder will still have the disorder later ; among preschoolers followed in mental health clinics is relatively high, about 50: over several years Campbell, 1995 ; . Problems presenting in mental health settings may have unique characteristics, such as a high degree of diagnostic comorbidity, that would increase problem stability above that seen in pediatric primary care. A recent study of children presenting in pediatric primary care, however, shows similar levels of stability for disruptive disorders among preschoolers Lavigne et al., 1998a ; . In most instances, program planners will want to concentrate on problems with high intraindividual stability rather than expending resources on more ephemeral problems. Determining the correlates of diagnostic stability can be important in understanding and predicting which children may have a more stable psychiatric disorder. In summarizing the results of studies using dimensional ratings of behavior problems using various questionnaires, Campbell 1995 ; reported that stability is associated with initial problem severity, maternal depression, parenting behavior, cognitive functioning, and family adversity. The studies reviewed examined children with psychological problems; none examined children who met DSM-based diagnostic criteria for psychiatric disorder. In a subsequent study involving children seen in pediatric primary care settings Lavigne.
DAVIDJACOBOWITZ. The possibility that dopamine is a neurohumor in the heart of M. mercenaria has been explored. Treatment of the heart and visceral ganglia with paraformaldehyde, according to and pemoline.
Monocyte and macrophage adhesion to mesangial matrix in the early stages of diabetic nephropathy.
The etiology and pathogenesis of Reye syndrome RS ; remain elusive. A disease largely of children, RS is characterized clinically by a potentially reversible noninflammatory, nonicteric hepatitis with encephalopathy and histopathologically by microvesicular fatty degeneration of hepatocytes with mitochondrial injury 1-6 ; . Although the incidence of RS has declined since its apparent peak in the late 1970s, mortality remains high 1-3 ; . Prodromal viral illnesses have been noted in many cases, and epidemiologic evidence has led to proposals that RS is a postviral manifestation of influenza types A and B and varicella infection 1, 7-9 ; . However, the typical histopathologic and biochemical abnormalities in RS suggest a toxin-mediated disease 1, 7, 8 ; . Aspirin has been identified as one potential mediator of hepatic mitochondrial insult in RS 1, 10-14 ; . Warnings that children with viral syndromes should not receive aspirin have been associated with an apparent decline in cases, but the relationship between pediatric aspirin use and the development of RS remains a matter of debate 1, 10-14 ; . Other viral agents, toxins, endotoxin, and cytokines 15-22 ; have also been implicated in the pathogenesis of RS. None of these associations has been conclusively confirmed. Progress in understanding the etiology of the hepatic defects in RS has been hampered by the lack of a generally accepted animal model. In the course of studying the pathogenesis of murine adenovirus type 1 MAV-1 ; infection, we infected CB-17 mice that carry the severe combined immunodeficiency SCID ; mutation. The parental CB-17 strain is a congenic BALB c mouse with only a single locus of the C57BL 6Ka and penicillamine.
NDA 20-955 S-006 Page 11 In multiple-dose Studies A and B, the most frequent adverse reactions following Ferrlecit were: Body as a Whole: injection site reaction 33% ; , chest pain 10% ; , pain 10% ; , asthenia 7% ; , headache 7% ; , abdominal pain 6% ; , fatigue 6% ; , fever 5% ; , malaise, infection, abscess, back pain, chills, rigors, arm pain, carcinoma, flu-like syndrome, sepsis. Nervous System: cramps 25% ; , dizziness 13% ; , paresthesias 6% ; , agitation, somnolence. Respiratory System: dyspnea 11% ; , coughing 6% ; , upper respiratory infections 6% ; , rhinitis, pneumonia. Cardiovascular System: hypotension 29% ; , hypertension 13% ; , syncope 6% ; , tachycardia 5% ; , bradycardia, vasodilatation, angina pectoris, myocardial infarction, pulmonary edema. Gastrointestinal System: nausea, vomiting and or diarrhea 35% ; , anorexia, rectal disorder, dyspepsia, eructation, flatulence, gastrointestinal disorder, melena. Musculoskeletal System: leg cramps 10% ; , myalgia, arthralgia. Skin and Appendages: pruritus 6% ; , rash, increased sweating. Genitourinary System: urinary tract infection. Special Senses: conjunctivitis, abnormal vision, ear disorder. Metabolic and Nutritional Disorders: hyperkalemia 6% ; , generalized edema 5% ; , leg edema, peripheral edema, hypoglycemia, edema, hypervolemia, hypokalemia. Hematologic System: abnormal erythrocytes 11% ; , anemia, leukocytosis, lymphadenopathy. Other Adverse Reactions Observed During Clinical Trials: In the single-dose post-marketing safety study in 1, 097 patients receiving Ferrlecit, the following additional events were reported in two or more patients: hypertonia, nervousness, dry mouth, and hemorrhage. Pediatric Patients: : In a clinical trial of 66 iron-deficient pediatric hemodialysis patients, 6 to 15 years of age, inclusive, who were receiving a stable erythropoietin dosing regimen, the most common adverse events, whether or not related to study drug, occurring in 5%, regardless of treatment group, were: hypotension 35% ; , headache 24% ; , hypertension 23% ; , tachycardia 17% ; , vomiting 11% ; , fever 9% ; , nausea 9% ; , abdominal pain 9% ; , pharyngitis 9% ; , diarrhea 8% ; , infection 8% ; , rhinitis 6% ; , and thrombosis 6% ; . More patients in the higher dose group 3.0 mg kg ; than in the lower dose group 1.5 mg kg ; experienced the following adverse events: hypotension 41% vs. 28% ; , tachycardia 21% vs. 13% ; , fever 15% vs. 3% ; , headache 29% vs. 19% ; , abdominal pain 15% vs. 3% ; , nausea 12% vs. 6% ; , vomiting 12% vs. 9% ; , pharyngitis 12% vs. 6% ; , and rhinitis 9% vs. 3% ; . OVERDOSAGE Dosages in excess of iron needs may lead to accumulation of iron in iron storage sites and hemosiderosis. Periodic monitoring of laboratory parameters of iron storage may assist in recognition of iron accumulation. Ferrlecit should not be administered in patients with iron overload. Serum iron levels greater than 300 g dL may indicate iron poisoning which is characterized by abdominal pain, diarrhea, or vomiting which progresses to pallor or cyanosis, lassitude, drowsiness, hyperventilation due to acidosis, and cardiovascular collapse. Caution should be exercised in interpreting serum iron levels in the 24 hours following the administration of Ferrlecit since many laboratory assays will falsely overestimate serum or transferrin bound iron by measuring iron still bound to the Ferrlecit complex. Additionally, in the assessment of iron overload, caution should be exercised in interpreting serum ferritin levels in the week following Ferrlecit administration since, in clinical studies, serum ferritin exhibited a non-specific rise which persisted for five days. The Ferrlecit iron complex is not dialyzable and pediatric.
Ferences were statistically significant, pain was the only variable which showed considerable change. Improvement in pain accounted for most of the improvement in the Constant-Murley and ASES scores. While there was a slight difference in some postoperative measurements between the HHR and TSR groups, this was not statistically significant Table III ; . All the values for effect size in Table II were above 0.8 whereas none in Table III reached a value of 0.5. The power of Student's t-test from the function data in Table III was 60%. A power of 80% is required to prevent a type-II error and the number of measurements of function would therefore have to be increased to 200. The preoperative pain and function measurements were significantly different p 0.001 ; from those of each follow-up year up to seven years with the mean differences always being greater than 6, 30 and 20 for pain, ASES score and Constant-Murley score, respectively. The sample for the follow-up at eight years was too small to show a significant difference. There was no significant change in pain or function between any of the follow-up years. Radiological analysis. There was lucency around the humeral component in one zone in 13% of shoulders Table IV ; , but none was grossly loose. Observations of the glenoid components indicated that in the pegged group 36% had lucency in at least one zone whereas 90% of keeled compo and pennyroyal.
POSTER SESSION II Friday October 26, 2007 12 Noon 2pm CELLULAR MOLECULAR BIOLOGY cv30 URINE ORGANIC ACID SCREENING FAILS TO LEAD TO THE DIAGNOSIS OF HYPER IGD SYNDROME HIDS ; . M. Goldman, Pediatric Gastroenterology, Uniformed Services University, Bethesda, MD; M. Goldman, K. Camp, D. Riera, Pediatric Gastroenterology, Walter Reed Army Medical Center, Washington DC, DC; S. Sparks, Genetics, Metabolism and the Center for Prenatal Evaluation, Children's National Medical Center, Washington DC, DC. KW is a year old female with a history of recurrent episodes of fever, vomiting, and diarrhea with an associated rash every 3 weeks since 2 weeks of age. These episodes would typically start with a fever followed by 4-5 bouts of emesis, which would then lead to loose stools and the development of a rash. She did not improve with symptomatic treatment. Comprehensive evaluations from pediatric allergy, dermatology, rheumatology, gastroenterology and metabolic disorders clinics were performed. She had numerous normal laboratory studies obtained when ill and well including Immunoglobulin panel, complement panel, chemistries, and complete blood counts. Urine organic acids were analyzed twice during illness and quantitatively reported as"no abnormalities found". Subsequently, urine mevalonic acid quantification was requested revealing a significantly elevated level of 48 g mg creatinine nl 0.25 0.14 g mg creatinine ; suggesting the diagnosis of HIDS. Mevalonic kinase gene analysis identified one of the common HIDS mutations V3771 ; in exon 10. With the clinical phenotype suggesting this disorder and only one common mutation found, we are pursuing full gene sequencing. The patient was given steroids for acute attacks and begun on antioxidant therapy to include co-enzyme Q10, vitamin C and vitamin E. Conclusion: Urine organic acids, even during illness, are not sufficient to lead to the diagnosis of HIDS. HEPATOBILIARY TRANSPLANT cv31 DIFFUSE XANTHOMATOSIS AND TYPE 2A HYPERLIPOPROTEINEMIA AFTER LIVER TRANSPLANTATION. R. Kellermayer, B.A. Carter, Pediatrics, Baylor College of Medicine, Houston, TX. A 4 year old male patient presented with elevated transaminases GGT and diffuse xanthomatosis 4 years after orthotopic liver transplantation OLT ; for ornithine transcarbamylase OTC ; deficiency. He received no medical care for one year, during which he developed tuberoeruptive xanthomas on his, joints, knuckles, trunk, bilateral pinnae, and extremities as well as striate xanthoma of the palms. Labs at presentation showed: AST 330 U L, ALT 209 U L, GGT 2139 U L, B Conj. 1.4 mg dL, Cholesterol 2124 mg dL nl= 135-200 ; , triglycerides 142 mg dL, normal doppler U S and MRCP, CMV and EBV neg. Liver biopsy revealed mild graft rejection, bile duct proliferation and possible cholangitis. A percutaneous transhepatic cholangiogram revealed no stricturing of bile ducts. Serum -sitosterol and campesterol were elevated, but not enough to suggest -sitosterolemia. A lipid profile showed type 2a hyperlipoproteinemia. Consecutive mutational analysis of the low density lipoprotein receptor gene LDLR, the most common gene associated with type 2a hyperlipoproteinemia ; was negative both from peripheral blood leukocytes and the transplanted liver. He did not respond to antibiotics. However, he slowly improved on intensified immunosuppression, low fat diet and oral Ezetimibe therapy. Cholesterol has normalized, xanthomas significantly regressed over six months, while transaminases and GGT improved, but remain mildly elevated. This is the first report of xanthomatosis secondary to type 2a hyperlipoproteinemia in a pediatric liver transplant recipient. Although the most common cause of type 2a hyperlipoproteinemia LDLR mutation ; was ruled out, a mutation in additional gene s ; recently linked to this dyslipidemia phenotype e.g. PCSK9 or APOB ; remain diagnostic possibilities. cv32 EPSTEIN-BARR VIRUS MENINGITIS AFTER LIVER TRANSPLANTATION. M.J. Alkalay, M.A. Russo, Pediatric Gastroenterology & Nutrition, University of Texas Southwestern Medical Center, Dallas, TX. A 17 y.o. immunosuppressed, female presented with jaundice and elevated transaminases. Past history was significant for type I autoimmune hepatitis leading to orthotopic liver transplant 6 months prior to presentation. Liver biopsy showed acute moderate cellular rejection without evidence of interface hepatitis. Despite high dose steroids, persistent transaminase elevation and biopsy confirmed rejection led to treatment with OKT-3. Four days after the last dose of OKT-3, she developed a severe headache, emesis, and neck pain stiffness. She had no antecedent rash, fever, or sick contacts. Her examination was notable for meningismus without encephalopathy or lymphadenopathy. CT of her head was normal. Lumbar puncture revealed: normal opening pressure, glucose and.
Angiolillo AL, Whitlock J, Chen MS, Krailo M and Reaman G 2006 ; Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia ADVL0022 ; : A children's oncology group report. Pediatric Blood and Cancer 46: 193-197 and pentamidine.
Mydriasis Inadequate mydriasis is often faced by the pediatric surgeons Use of strong mydriatic agent Eg: Atropine sulphate ; in an ointment base, prior to surgery , may enhance dilatation , Use of intracameral diluted adrenaline and viscoelastic helps in enlarging the pupil size. Wound Construction Anterior Approach ; Site: While the temporal wound presents the same advantages in children as it dose in adults, the location is more easily traumatized by children. The superior approach allows the wound to be protected by the brow and the Bells phenomenon Children have thin sclera and markedly decreased scleral rigidity. Collapse of the anterior chamber and prolapse of iris tissue are also much more common. Therefore, wounds should be constructed to provide a snug fit for instruments that pass in to the anterior chamber. An anterior chamber entry of 3mm or less is sufficient for capsulotomy, I A. When a rigid IOL is being implanted a scleral tunnel is preferred. Scleral tunnel wounds decreased the incidence of iris prolapse into the wound and AC collapse during surgery. When a foldable IOL is being implanted, a corneal tunnel is preferred since it leaves conjunctiva undisturbed. Viscoelastic substances VES ; High molecular VES is most commonly used in pediatric cataract surgery to effectively resist the increased tendency for anterior chamber collapse, due to decrease scleral rigidity and positive vitreous pressure. This VES helps to maintain a deep anterior chamber and a lax anterior capsule, facilitating anterior capsulorhexis; holds back the convex posterior and pegasys.
MCL is an aggressive B cell lymphoma with poor prognosis and resistance to current chemotherapy regimens 1 ; . Novel, rationally based, and tumor-specific treatments are therefore needed to improve patient outcome. Consequently, agents such as TRAIL that can selectively target tumor cells without causing toxicity to surrounding tissue are crucial in clinical approaches to MCL treatment. This study provides evidence that the TRAIL apoptotic pathway is functional in the majority of primary and established MCL cell lines. We also demonstrate that sensitivity to TRAIL in MCL cells is not linked to TRAIL receptor expression. TRAIL-induced apoptosis has recently been described as dependent on TRAIL-RI and or TRAIL-R2 dosage in B cell lymphomas, and associated with the 8p21.3 deletion, frequently observed in the leukemic form of MCL 16 ; . Our results show that 8p genomic loss is associated neither with response to TRAIL, with mRNA levels, nor with the membrane expression of the TRAIL receptors. Moreover, analysis of DR4 and DR5 expression reveals that cell lines with the lowest sensitivity to TRAIL Rec-1, Granta-519, and JVM-2 ; express the highest amounts of receptors. A lack of correlation between sensitivity to TRAIL cytotoxic effect and membrane expression of its receptors has been described in other models 21, 22 ; . Although a frequent polymorphism affects the TRAIL receptor locus in MCL cells, no mutations are observed in their death domain 23 ; . Thus, in MCL cells resistant to TRAIL, defects in TRAIL-dependent apoptotic signaling might occur downstream of the ligand-receptor interaction. Overexpression of some IAPs, such as XIAP, or enhanced Akt activity has been reported to confer resistance to TRAIL-induced apoptosis in cancer cells 24 26 ; . TRAIL sensitivity can also be modulated by the expression levels of c-FLIP, Bcl-xL, p53, protein kinase C, MAPK, or c-myc 27, 28 ; . Among these possible regu and pentasa.
Order generic Pediatric online
Recognized. Untreated macaques infected with virulent isolates such as SIVmac251 have higher viremia, lower cell-mediated antiviral immune responses, and a more rapid disease course than HIV-infected humans30. As discussed further in this review, an antiretroviral drug becomes less effective in suppressing viremia without the assistance of effective antiviral immune responses. As the drugs available at that time were not very potent in suppressing viremia in HIV-infected humans, it is now no surprise that they were even less effective in suppressing viremia in immunodeficient SIV-infected macaques. Finally, sensitive assays to accurately quantitate viremia were not available at that time. Many of these problems have been solved in the past decade. Sensitive assays, similar to those used to monitor HIV infection of humans, have been developed to monitor virus replication in SIV-infected macaques, including quantitative viral RNA assays31-33. The development of a pediatric SIV model has also been very useful, as the more uniformly rapid disease course ~ 3 to months ; observed in infant macaques infected with virulent SIV isolates permits evaluation of drug efficacy, including viremia and disease-free survival, in a relatively short time29, 34, 35. Infant macaques are also easier to handle for drug administration and require less drug, which is useful especially for compounds that are initially very expensive to produce in test quantities. The first report on the RT inhibitor tenofovir 9-[2- R ; - phosp honomethoxy ; propyl]adenine; PMPA ; in 1995 was a milestone in validating this animal model because it was the first compound found to be highly effective against SIV infection34, 36. The strong therapeutic benefits observed with tenofovir in the monkey studies have been predictive of tenofovir's efficacy in HIV-infected humans, and have contributed to its clinical development37-39. Altogether, these developments over the past decade have sparked further interest in using nonhuman primate models for antiretroviral drug studies.
Pediatric oral
|